Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]

Antzeko izenburuak

• A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells
  nork: Chi-Wei Chen, et al.
  Argitaratua: (2016-04-01)
• A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells()()
  nork: Chen, Chi-Wei, et al.
  Argitaratua: (2016)
• Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]
  nork: Sanjiv, Kumar, et al.
  Argitaratua: (2017)
• Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]
  nork: Kumar Sanjiv, et al.
  Argitaratua: (2017-04-01)
• PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells()()
  nork: Sanjiv, Kumar, et al.
  Argitaratua: (2014)